Microencapsulation of protein into biodegradable matrix: a smart solution cross-linking technique

References

• Akers MJ, Nail SL. Top 10 current technical issues in parenteral science. Pharm Technol 1994; 18: 26–36
   Google Scholar
• Arshady R. Albumin microspheres and microcapsules: Methodology of manufacturing techniques. J Controlled Release 1990; 14: 111–31
   Web of Science ®Google Scholar
• Banga AK. Therapeutic peptides and proteins: Formulation, processing, and delivery systems. CRC/Taylor & Francis, Boca Raton, FL 2006
   Google Scholar
• Barrett TJ, Blake PA, Brown SL, Hoffman K, Llort JM, Feeley JC. Enzyme-linked immunosorbent assay for detection of human antibodies to Salmonella typhi Vi antigen. J Clin Microbiol 1983; 17: 625–7
   PubMed Web of Science ®Google Scholar
• Bauer HH, Muller M, Goette J, Merkle HP, Fringeli UP. Interfacial adsorption and aggregation associated changes in secondary structure of human calcitonin monitored by ATR-FTIR spectroscopy. Biochemistry 1994; 33: 12276–82
   PubMed Web of Science ®Google Scholar
• Bejugam NK, Uddin AN, Gayakwad SG, D'souza MJ. Formulation and evaluation of albumin microspheres and its enteric coating using a spray-dryer. J Microencapsulation 2008; 25: 577–83
   PubMed Web of Science ®Google Scholar
• Bosse D, Praus M, Kiessling P, Nyman L, Andresen C, Waters J, Schindel F. Phase I comparability of recombinant human albumin and human serum albumin. J Clin Pharmacol 2005; 45: 57–67
   PubMed Web of Science ®Google Scholar
• Broadhead J, Rouan SK, Hau I, Rhodes CT. The effect of process and formulation variables on the properties of spray-dried beta-galactosidase. J Pharm Pharmacol 1994; 46: 458–67
   PubMed Web of Science ®Google Scholar
• Burger JJ, Tomlinson E, Mulder EMA, McVie JG. Albumin microspheres for intra-arterial tumour targeting. I. Pharmaceutical aspects. Int J Pharm 1985; 23: 333–44
   Google Scholar
• Burgess DJ, Davis SS, Tomlinson E. Potential use of albumin microspheres as a drug delivery system. I. Preparation and in vitro release of steroids. Int J Pharm 1987; 39: 129–36
   Web of Science ®Google Scholar
• Cauchy M, D’Aoust S, Dawson B, Rode H, Hefford MA. Thermal stability: A means to assure tertiary structure in therapeutic proteins. Biologicals 2002; 30: 175–85
   PubMed Web of Science ®Google Scholar
• Chaubal MV. Human serum albumin as a pharmaceutical excipient. Drug Deliv Technol 2005; 5: 22–3
   Google Scholar
• Chen CQ, Lin W, Coombes AG, Davis SS, Illum L. Preparation of human serum albumin microspheres by a novel acetone-heat denaturation method. J Microencapsulation 1994; 11: 395–407
   PubMed Web of Science ®Google Scholar
• Evans S, Grassam P. Considerations for parenteral dosage form development of natural alpha interferon. J Parenter Sci Technol 1986; 40: 83–7
   PubMedGoogle Scholar
• Ferry BL, Misbah SA, Stephens P, Sherrell Z, Lythgoe H, Bateman E, Banner C, Jones J, Groome N, Chapel HM. Development of an anti-Salmonella typhi Vi ELISA: Assessment of immunocompetence in healthy donors. Clin Exp Immunol 2004; 136: 297–303
   PubMed Web of Science ®Google Scholar
• Gorin G, Wang SF, Papapavlou L. Assay of lysozyme by its lytic action on M. lysodeikticus cells. Anal Biochem 1971; 39: 113–27
   PubMed Web of Science ®Google Scholar
• Green MD, D'souza MJ, Holbrook JM, Wirtz RA. In vitro and in vivo evaluation of albumin-encapsulated primaquine diphosphate prepared by nebulization into heated oil. J Microencapsulation 2004; 21: 433–44
   PubMed Web of Science ®Google Scholar
• Grossowicz N, Ariel M. Methods for determination of lysozyme activity. Methods Biochem Anal 1983; 29: 435–46
   PubMedGoogle Scholar
• Haswani D, 2005. Evaluation of microencapsulated gentamicin on Escherichia coli in Gram negative sepsis, PhD Dissertation, Department of Pharmaceutical Sciences, Mercer University
   Google Scholar
• Haswani DK, Nettey H, Oettinger C, D'souza MJ. Formulation, characterization and pharmacokinetic evaluation of gentamicin sulphate loaded albumin microspheres. J Microencapsulation 2006; 23: 875–86
   PubMed Web of Science ®Google Scholar
• He J, Feng M, Zhou X, Ma S, Jiang Y, Wang Y, Zhang H. Stabilization and encapsulation of recombinant human erythropoietin into PLGA microspheres using human serum albumin as a stabilizer. Int J Pharm 2011; 416: 69–76
   PubMed Web of Science ®Google Scholar
• Jena I, 2005. Determination of secondary structure in proteins by Fourier transform infrared spectroscopy (FT-IR). Image Library of Biological Macromolecules
   Google Scholar
• Jordan SL, Russo MR, Blessing RL, Theis AB. Inactivation of glutaraldehyde by reaction with sodium bisulfite. J Toxicol Environ Health 1996; 47: 299–309
   PubMed Web of Science ®Google Scholar
• Jyothi NV, Prasanna PM, Sakarkar SN, Prabha KS, Ramaiah PS, Srawan GY. Microencapsulation techniques, factors influencing encapsulation efficiency. J Microencapsulation 2010; 27: 187–97
   PubMed Web of Science ®Google Scholar
• Kim DH, Jun SW, Kim MS, Lee S, Hwang SJ. Micronisation of lysozyme suitable for pulmonary drug delivery using solution enhanced dispersion by supercritical fluids. Controlled Release Society, Miami, FL 2005
   Google Scholar
• Labrude P, Rasolomanana M, Vigneron C, Thirion C, Chaillot B. Protective effect of sucrose on spray drying of oxyhemoglobin. J Pharm Sci 1989; 78: 223–9
   PubMed Web of Science ®Google Scholar
• Liao YH, Brown MB, Martin GP. Turbidimetric and HPLC assays for the determination of formulated lysozyme activity. J Pharm Pharmacol 2001; 53: 549–54
   PubMed Web of Science ®Google Scholar
• Linders LJM, Meerdink G, Van’t Riet K. Influence of temperature and drying rate on the dehydration inactivation of Lactobacillus plantarum. Trans IchemE 1996; 74: 110–4
   Google Scholar
• Malzert A, Boury F, Renard D, Robert P, Proust JE, Benoit JP. Influence of some formulation parameters on lysozyme adsorption and on its stability in solution. Int J Pharm 2002; 242: 405–9
   PubMed Web of Science ®Google Scholar
• Morris NJ, Warburton B. Three-ply walled w/o/w microcapsules formed by a multiple emulsion technique. J Pharm Pharmacol 1982; 34: 475–9
   PubMed Web of Science ®Google Scholar
• Natsume H, Sugibayashi K, Kazuhiko K, Morimoto Y, Shibata T, Fujimoto S. Preparation and evaluation of biodegradable albumin microspheres containing mitomycin C. Int J Pharm 1990; 58: 79–87
   Google Scholar
• Nettey H, Haswani D, Oettinger CW, D'souza MJ. Formulation and testing of vancomycin loaded albumin microspheres prepared by spray-drying. J Microencapsulation 2006; 23: 632–42
   PubMed Web of Science ®Google Scholar
• Orive G, Carcaboso AM, Hernandez RM, Gascon AR, Pedraz JL. Biocompatibility evaluation of different alginates and alginate-based microcapsules. Biomacromolecules 2005; 6: 927–31
   PubMed Web of Science ®Google Scholar
• Orive G, Hernandez RM, Gascon AR, Calafiore R, Chang TM, de Vos P, Hortelano G, Hunkeler D, Lacik I, Shapiro AM, et al. Cell encapsulation: Promise and progress. Nat Med 2003; 9: 104–7
   PubMed Web of Science ®Google Scholar
• Shah MV, de Gennaro MD, Suryakasuma H. An evaluation of albumin microcapsules prepared using a multiple emulsion technique. J Microencapsulation 1987; 4: 223–38
   PubMed Web of Science ®Google Scholar
• Silva CJSM, Sousa F, Gubitz G, Cavaco-Paulo A. Chemical modifications on proteins using glutaraldehyde. Food Tech Biotechnol 2004; 42: 51–6
   Web of Science ®Google Scholar
• Tzannis ST, Prestrelski SJ. Activity-stability considerations of trypsinogen during spray drying: Effects of sucrose. J Pharm Sci 1999a; 88: 351–9
   PubMed Web of Science ®Google Scholar
• Tzannis ST, Prestrelski SJ. Moisture effects on protein–excipient interactions in spray-dried powders. Nature of destabilizing effects of sucrose. J Pharm Sci 1999b; 88: 360–70
   PubMed Web of Science ®Google Scholar
• US Department of Labor, OSHA. OSHA analytical methods manual, Method 64, Glutaraldehyde. OSHA Analytical Laboratory, Salt Lake City, UT 1987
   Google Scholar
• Zhao D, Zhao X, Zu Y, Li J, Zhang Y, Jiang R, Zhang Z. Preparation, characterization, and in vitro targeted delivery of folate-decorated paclitaxel-loaded bovine serum albumin nanoparticles. Int J Nanomedicine 2010a; 5: 669–77
   PubMed Web of Science ®Google Scholar
• Zhao L, Yang B, Dai X, Wang X, Gao F, Zhang X, Tang J. Glutaraldehyde mediated conjugation of amino-coated magnetic nanoparticles with albumin protein for nanothermotherapy. J Nanosci Nanotechnol 2010b; 10: 7117–20
   PubMed Web of Science ®Google Scholar
• Zolle I, Rhodes BA, Wagner HN, Jr. Preparation of metabolizable radioactive human serum albumin microspheres for studies of the circulation. Int J Appl Radiat Isot 1970; 21: 155–67
   PubMedGoogle Scholar